We are thrilled to have been placed first in Tech Nation highly competitive #RisingStars Grand Final at London Tech Week!🌟 The high calibre of our fellow finals placements makes our win even more impactful and meaningful. It is a tremendous honour to stand alongside such remarkable finalists. Congratulations to Peter Gilleece from Vikela for securing 2nd place and to Monica Saavedra from Lambda agri for clinching 3rd place. This finals victory is a testament to each company’s hard work and innovation, across such diverse and competitive fields and serves to open new doors for collaboration, investment, and growth. A huge thank you to all the judges—Tej Lalvani of Vitabiotics Ltd, Deirdre O'Neill of Hertility, Julia Hoggett of the London Stock Exchange, Oliver Kent-Braham of Marshmallow, and Simon Bumfrey of HSBC Innovation Banking—for their invaluable insights and questions. And a special shoutout to June Sarpong OBE for her fantastic hosting and to the entire Tech Nation and Founders Forum Group team, Chantelle Young for organising and bringing the #RisingStars event to life. 🚀 #Innovation #TechNation #RisingStars #Novai #DARCtechnology #LondonTechWeek
Novai
Biotechnology Research
Reading, England 3,921 followers
DARC, a retinal biomarker with AI, advancing drug development for AMD & glaucoma therapeutics
About us
Early Detection Prevents Blindness and Disability: Novai is on a mission to combat blindness and disability by pioneering early detection and intervention for eye and brain diseases. At the heart of Novai's innovation is the DARC technology (Detection of Apoptosing Retinal Cells), a novel combination of a proprietary biologic and Artificial Intelligence (AI). The Eye is a Window on to the Brain: DARC stands alone as the sole technology with the ability to observe single cell stress and programmed cell death in the retina. This breakthrough positions DARC as the go-to biomarker to inform clinical decision-making in both ophthalmic and neurodegenerative diseases such as macular degeneration, glaucoma, diabetes, Parkinson's, multiple sclerosis and Alzheimer's. Expertise, Experience and Traction: The company boasts an expert and experienced leadership and advisory team, strong IP rights, and a clear strategy targeting a $40 billion market. Novai has generated £4.2 million from signed sales contracts, contributing to drug development and risk mitigation for Pharma companies using DARC. Series A for Mainstream Adoption: With £4.5 million in investments and £3.3 million in non-dilutive funding secured, Novai is currently on a fundraising drive to raise an additional £10 million towards approval of its use in clinic. DARC has been developed by Professor M Francesca Cordeiro at University College London through Wellcome Trust funding and is now approved as an exploratory biomarker by the FDA & MHRA. Novai is headquartered in Reading, UK. For more information, please visit our website www.novai.co.uk
- Website
-
http://www.novai.co.uk
External link for Novai
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Reading, England
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Biotechnology, Drug Development, Pharmaceutical, Opthalmology, Artificial Intelligence, Glaucoma, Age-related Macular Degeneration, Retinal, Neurodegeneration, Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, and Biomarker
Locations
-
Primary
9 Greyfriars Road
SPACES
Reading, England RG1 1NU, GB
Employees at Novai
-
Natalie Pankova, PhD
Global Leader in Healthcare Technology & Innovation | Venture Capital Pre-Seed Investor, Board Member & Advisor
-
Jennifer Raffrenato
Project Manager | Biotech & Pharma | Clinical trials management | PRINCE2
-
Jonathan Young
Data Scientist at biotechnology company developing biomarkers for opthalmic conditions
-
Hashir Gill
Business Development Associate at Novai
Updates
-
Following a highly competitive selection process, Novai is thrilled to have been chosen as one of only two ophthalmology companies to participate in the Startup Creasphere program by Plug and Play Tech Center and Roche. It's an honour to be recognised alongside other innovative projects, including deepeye - preventing blindness from Germany and we are grateful for the opportunity. We are committed to making a positive impact on patient care and are excited for the final stretch of the program. Thank you to the organisers and the expert jury for this incredible opportunity. 😁 👏
¡Enhorabuena a los finalistas de Startup Creasphere en oftalmología y hepatocarcinoma! 👏 😀 Nos alegra anunciar que cuatro #startups y tres proyectos hospitalarios han sido seleccionados para la final de nuestro programa de #innovación, junto con Plug and Play Tech Center, que busca impulsar soluciones disruptivas para mejorar la sanidad. 🔬 En el área de #oftalmología: ➡️ Novai (Reino Unido, 2020) ➡️ deepeye - preventing blindness (Alemania, 2021) ➡️ Proyecto Hospitalario del Hospital Universitario de Navarra: NaIA-DMAE ➡️ Iniciativa Naveta de la Asociación de Farmacéuticos de los Servicios de Atención Primaria de las Islas Baleares (FARUPEIB) En el área de #hepatocarcinoma: ➡️ Naru Intelligence (España, 2017) ➡️ Higia (España, 2023) ➡️ Proyecto Hospitalario Hepato-Care del Hospital Universitario Miguel Servet de Zaragoza Un jurado de expertos ha seleccionado estos proyectos después de una rigurosa evaluación, teniendo en cuenta criterios como la calidad de la propuesta, la experiencia del equipo, el impacto en la vida del #paciente y el beneficio para los hospitales y los profesionales sanitarios. 👥 Gracias a todas las startups y proyectos hospitalarios que participaron en el Selection Day. 😉 Vuestro talento, pasión e innovación son esenciales para avanzar en el desarrollo de soluciones que mejoren la #salud de las personas. ⚕️ ¡Esperamos con ganas la recta final! 🔜 Roche
-
We are delighted to announce that we were runners-up at the Rising Stars East Finals with an extremely impressive and varied group of Start Up Founders in Cambridge on Tuesday 13th May 2024. A huge congratulations to all the incredible companies that took part in the pitch event!👏👏 Thanks to Chris Bruce, Oonagh Phelan & Sophie Clarke at Cambridge Wireless Ltd for organising this event. #UKInnovation #MedTech #HealthTech #Biomarker #WeAreTechNation #WeAreTNRisingStars #technation #startups #scaleups #founders #uktech Lambda agri STRAW INNOVATIONS LTD Neuro XR Cloud Contracts 365 Other Skies Safepoint Tech Educators Tech1M (Techstars ‘23) Chantelle Young
-
-
Yet another win for Novai! We are proud to share that we have made it to the regional finals for the East of England for the prestigious Tech Nation Rising Stars competition. We look forward to attending the final pitch on 13th May in Cambridge and meeting the rest of the finalists! #UKInnovation #MedTech #HealthTech
-
-
We are proud to be selected once again as finalists in the Medtech & Healthtech StartUp of the Year category at the South East regional UK StartUp Awards 2024! #UKInnovation #MedTech #HealthTech
-
-
DARC's exciting journey from bench to bedside and its potential to revolutionise the early detection and treatment of blinding diseases have been featured in this new article in Glaucoma Today #biomarker #glaucoma #amd #earlydetection https://lnkd.in/e-qrpZb7
DARC: From Bench to Bedside - Glaucoma Today
glaucomatoday.com
-
This #WorldGlaucomaDay let's come together to raise awareness and support those affected by this silent thief of sight. Novai is helping build a future where glaucoma can be detected and treated early, well before permanent vision loss. #UnitingForAGlaucomaFreeWorld #GlaucomaAwareness
-
-
#digitalhealth #healthcare #healthcareinnovation #healthcareconsulting #ophthalmology #biomarker #clinicaltrials #artificialintelligence #artificialintelligenceinhealthcare #novai #womenshistorymonth
As we celebrate #WomensHistoryMonth, ARVO member M. Francesca Cordeiro, MD, PhD — chair of #ophthalmology at Imperial College London — shares with #ARVONews her passion for #TranslationalResearch, her recent DARC technology start-up and advice for young women considering careers in ophthalmology. https://bit.ly/4ajQaRl #WomenInScience
-
-
Today, we would like to highlight and acknowledge Natalie Pankova, PhD, our Non-Executive Director, who has been key in the expansion of Novai’s Artificial Intelligence programme. Dr Pankova is widely recognised as an international Digital Health Expert, and is a regular contributor, advisor, mentor and speaker in the use of technological advancements in healthcare, including for the World Health Organization and Parliamentary Panels. As International Women’s Week commences today, and in the lead up, to International Women's Day on March 8th, Novai would like to celebrate the hard work and dedication of all their female team-members. 🎉 #internationalwomensday2024 #internationalwomensweek #digitalhealth #healthcare #healthcareinnovation #healthcareconsulting #ophthalmology #biomarker #clinicaltrials #artificialintelligence #artificialintelligenceinhealthcare #womenentrepreneurs #womenandgirlsinscience #womenexecutives #worldhealthorganization
-
-
We are honoured to receive mention of Novai's technology in the World Research Reports' post highlighting advances in Multiple Sclerosis. Visualising the retina affords a unique opportunity to identify disease affecting not just the eye, but of the central nervous system. Novai’s DARC technology enables in vivo localisation and stratification of single cell stress revealing distinct mechanisms of early disease, potentially leading to faster, better treatment with superior prognosis. #multiplesclerosis #ms #mswarrior #msawareness #chronicillness #multiplesclerosisawareness #msfighter #invisibleillness #autoimmunedisease #thisisms #multiplesclerosisfighter #multiplesclerosiswarrior #msstrong #chronicpain #mssucks #mssociety #spoonie #mslife #mswarriors #multiplesklerose #mssupport #curems #fibromyalgia #mscommunity #livingwithms #fuckms #multiplesclerosissociety #spoonielife #autoimmune #msfamily #artificialintelligence #artificialintelligenceinhealthcare #ophthalmology #biomarker
Multiple Sclerosis Therapeutics Market Outlook and Geography Forecast till 2031 !! #Multiple #Sclerosis #Therapeutics Market Size, Share & Trends Analysis Report Multiple Sclerosis Therapeutics market drug class (Immunomodulators, Immunosuppressant) Multiple Sclerosis Therapeutics market mode of administration (Injectable, Infused/Intravenous, Oral), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031 🌐IMIR Market Research Pvt. Ltd. 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 👇 https://lnkd.in/dn--Xx7G 📚 𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞:- 👇 Alexion Pharmaceuticals, Inc. Inc. Alkermes Allergan Amgen. Antharis Therapeutics, Inc. AstraZeneca Atara Biotherapeutics Inc. Bayer Bayer Schering Pharma Brainstorm Cell Therapeutics Bristol-Myers Squibb Pharma Company Caraway Therapeutics, Inc. Convelo Therapeutics, Inc Eli Lilly and Company EMD Serono, Inc.. F. Hoffmann-La Roche Ltd Frequency Therapeutics GSK Indivi Johnson & Johnson Kyverna Therapeutics Mallinckrodt Pharmaceuticals MedRhythms, Inc. Merck & Co., Inc. Mitsubishi Tanabe Pharma Corporation Novai Novartis Olatec Therapeutics Opexa Therapeutics Pfizer. Progentec Diagnostics, Inc. Rebify Rewind Therapeutics Sanofi Teva Pharmaceuticals TG Therapeutics, Inc. Topas Therapeutics GmbH VBL Therapeutics (Nasdaq:VBLT) Voyager Therapeutics, Inc. #multiplesclerosis #ms #mswarrior #msawareness #chronicillness #multiplesclerosisawareness #msfighter #invisibleillness #autoimmunedisease #thisisms #multiplesclerosisfighter #multiplesclerosiswarrior #msstrong #chronicpain #mssucks #mssociety #spoonie #mslife #mswarriors #multiplesklerose #mssupport #curems #fibromyalgia #mscommunity #livingwithms #fuckms #multiplesclerosissociety #spoonielife #autoimmune #msfamily
-